Stuart A. Arbuckle, EVP, COO: Vertex Pharmaceuticals VRTX Sell · Filed 24/02/13

Trade details

Type: Insider sale
Amount: $1,804,930.8
Shares · price: 4,295 sh · $420.24 a share
Held after: 75,718 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Stuart A. ArbuckleEVP, COO
Trade date: 24/02/12
Filed: 24/02/13
Days to filing: 1 days

Sold 5.4% of holdings

Share of holding sold: 5.4%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/13~24/03/13

Stuart A. Arbuckle's recent trades

Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$29.7K
69 sh
$29.7K
Filed 24/05/17
Traded 24/05/15
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2.1M
5,034 sh
$2.1M
Filed 24/02/27
Traded 24/02/26
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.5M
3,603 sh
$1.5M
Filed 24/02/23
Traded 24/02/21
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2M
4,804 sh
$2M
Filed 24/02/21
Traded 24/02/20
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3.4M
8,603 sh
$3.4M
Filed 23/12/15
Traded 23/12/13